- Home
- GERN vs YRD Comparison
GERN vs YRD Comparison
Compare GERN & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- YRD
- Stock Information
- Founded
- GERN 1990
- YRD 2012
- Country
- GERN United States
- YRD China
- Employees
- GERN N/A
- YRD N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- YRD Finance: Consumer Services
- Sector
- GERN Health Care
- YRD Finance
- Exchange
- GERN Nasdaq
- YRD Nasdaq
- Market Cap
- GERN 700.6M
- YRD 584.1M
- IPO Year
- GERN 1996
- YRD 2015
- Fundamental
- Price
- GERN $1.17
- YRD $5.68
- Analyst Decision
- GERN Buy
- YRD
- Analyst Count
- GERN 8
- YRD 0
- Target Price
- GERN $3.71
- YRD N/A
- AVG Volume (30 Days)
- GERN 9.2M
- YRD 79.4K
- Earning Date
- GERN 08-06-2025
- YRD 08-19-2025
- Dividend Yield
- GERN N/A
- YRD 7.75%
- EPS Growth
- GERN N/A
- YRD N/A
- EPS
- GERN N/A
- YRD 2.13
- Revenue
- GERN $116,293,000.00
- YRD $824,411,631.00
- Revenue This Year
- GERN $161.44
- YRD N/A
- Revenue Next Year
- GERN $53.06
- YRD N/A
- P/E Ratio
- GERN N/A
- YRD $2.67
- Revenue Growth
- GERN 22264.04
- YRD 13.14
- 52 Week Low
- GERN $1.09
- YRD $4.12
- 52 Week High
- GERN $4.89
- YRD $9.20
- Technical
- Relative Strength Index (RSI)
- GERN 39.34
- YRD 35.05
- Support Level
- GERN $1.20
- YRD $5.85
- Resistance Level
- GERN $1.37
- YRD $5.99
- Average True Range (ATR)
- GERN 0.08
- YRD 0.19
- MACD
- GERN -0.01
- YRD -0.03
- Stochastic Oscillator
- GERN 28.57
- YRD 6.39
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.